Evidence map›Paper›PMID 36831483›Full record

ArticleCancers2023

Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study.

Eric Leblanc, Fabrice Narducci, Gwenaël Ferron, Audrey Mailliez, Jean-Yves Charvolin, El Hajj Houssein, Frédéric Guyon, Virginie Fourchotte, Eric Lambaudie, Agathe Crouzet and 14 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01608074 naactive not recruitingnot on this map

Radical Fimbriectomy for Young BRCA Mutation Carriers at Risk of Pelvic Serous Carcinoma

TypeinterventionalSponsorCentre Oscar LambretRan2012 to 2033Enrolled123ConditionsBRCA1 Mutation, BRCA2 Mutation, Hereditary Breast and Ovarian CancerArmsRadical fimbriectomy, Histopathology SEE-FIM
NCT07532434 recruitingnot on this mapstarted 2025, after this paper: background citation

A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer

Typeobservational_patient_registrySponsorPeking University Third HospitalRan2025 to 2035Enrolled480ConditionsOvarian Cancer, Breast Cancer
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Global epidemiology of epithelial ovarian cancer.Nature reviews. Clinical oncology · 2024
    Review
  4. Review
  5. Article
  6. TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 1 country.

Eric LeblancDepartment of Gynecologic Oncology, Centre Oscar Lambret, 3 rue Frédéric Combemale, 59020 Lille, France.ORCID 0000-0001-7299-0339
Fabrice NarducciDepartment of Gynecologic Oncology, Centre Oscar Lambret, 3 rue Frédéric Combemale, 59020 Lille, France.
Gwenaël FerronCentre Claudius Regaud, 31300 Toulouse, France.
Audrey MailliezMedical Oncology Department, Centre Oscar Lambret, 59020 Lille, France.ORCID 0000-0002-0475-8631
Jean-Yves CharvolinClinique du Bois, 59000 Lille, France.
El Hajj HousseinDepartment of Gynecologic Oncology, Centre Oscar Lambret, 3 rue Frédéric Combemale, 59020 Lille, France.
Frédéric GuyonInstitut Jean-Alban Bergonié, 33076 Bordeaux, France.ORCID 0000-0002-2647-3004
Virginie FourchotteInstitut Curie, 75248 Paris, France.
Eric LambaudieInstitut Paoli-Calmettes, 13009 Marseille, France.
Agathe CrouzetCentre Henri Becquerel, 76038 Rouen, France.
Yves FoucheCentre Antoine Lacassagne, 06100 Nice, France.
Sébastien GouyInstitut Gustave Roussy, 94805 Villejuif, France.
Pierre CollinetHôpital Jeanne de Flandre, CHRU, 59000 Lille, France.
Frédéric CaquantHôpital Privé de Villeneuve d'Ascq, 59650 Villeneuve-d'Ascq, France.ORCID 0000-0001-6453-1933
Christophe PomelCentre Jean Perrin, 63011 Clermont-Ferrand, France.
François GolfierHospices Civils de Lyon, 69002 Lyon, France.
Véronique Vaini-CowenPolyclinique du Parc Rambot, 13100 Aix en Provence, France.
Isabelle FournierINSERM U1192, Université de Lille, 59000 Lille, France.ORCID 0000-0003-1096-5044
Michel SalzetINSERM U1192, Université de Lille, 59000 Lille, France.ORCID 0000-0003-4318-0817
Emmanuelle TreschBiostatistics Unit, DRCI, Centre Oscar Lambret, 59020 Lille, France.
Alicia ProbstSponsor Unit, DRCI, Centre Oscar Lambret, 59020 Lille, France.ORCID 0000-0002-4252-9565
Anne-Sophie LemairePathology Department, Centre Oscar Lambret, 59020 Lille, France.
Marie-Cécile Le DeleySponsor Unit, DRCI, Centre Oscar Lambret, 59020 Lille, France.ORCID 0000-0002-2946-4592
Delphine HudryDepartment of Gynecologic Oncology, Centre Oscar Lambret, 3 rue Frédéric Combemale, 59020 Lille, France.ORCID 0000-0002-5599-3359
Inserm · FRCentre Oscar Lambret · FRCentre Antoine Lacassagne · FRCentre Henri BecquerelCentre Jean Perrin · FRCentre Régional d’Innovation et de Transferts Technologiques des Industries du Bois · FRHôpital Jeanne de Flandre · FRHospices Civils de Lyon · FRInstitut Bergonié · FRInstitut Claudius Regaud · FRInstitut Curie · FRInstitut Gustave Roussy · FRInstitut Paoli-Calmettes · FR

Funding

French National Cancer Institute PHRC 2011-06
6 · The paper itself

Abstract

Risk-reducing salpingo-oophorectomy is the gold standard for the prophylaxis of ovarian cancer in high-risk women. Due to significant adverse effects, 20-30% of women delay or refuse early oophorectomy. This prospective pilot study (NCT01608074) aimed to assess the efficacy of radical fimbriectomy followed by a delayed oophorectomy in preventing ovarian and pelvic invasive cancer (the primary endpoint) and to evaluate the safety of both procedures. The key eligibility criteria were pre-menopausal women ≥35 years with a high risk of ovarian cancer who refused a risk-reducing salpingo-oophorectomy. All the surgical specimens were subjected to the SEE-FIM protocol. From January 2012 to October 2014, 121 patients underwent RF, with 51 in an ambulatory setting. Occult neoplasia was found in two cases, with one tubal high-grade serous ovarian carcinoma. Two patients experienced grade 1 intraoperative complications. No early or delayed grade ≥3 post-operative complications occurred. After 7.3 years of median follow-up, no cases of pelvic invasive cancer have been noted. Three of the fifty-two patients developed de novo breast cancer. One BRCA1-mutated woman delivered twins safely. Twenty-five patients underwent menopause, including fifteen who had received chemotherapy for breast cancer, and twenty-three underwent menopause before the delayed oophorectomy, while two did not undergo a delayed oophorectomy at all. Overall, 46 women underwent a delayed oophorectomy. No abnormalities were found in any delayed oophorectomy specimens. Radical fimbriectomy followed by delayed oophorectomy appears to be a safe and well-tolerated risk-reducing approach, which avoids early menopause for patients with a high risk of breast and ovarian cancer.

Indexed as

delayed oophorectomyearly menopausehigh risk of breast and ovarian cancerovarian cancer preventionradical fimbriectomyrisk-reducing surgery

Identifiers

PMID36831483
PMCPMC9954021
OpenAlexW4319969435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.